Assess the Effect of Erythromycin on the Rate of Success in Placement of a Self-propelled Feeding Tube

Phase 4

Completed

• Conditions: Pancreatitis
• Interventions: Drug: Placebo; Drug: Erythromycin

• Registration Number: NCT00999232
• Lead Sponsor: Canisius-Wilhelmina Hospital

Brief Summary

The purpose of this study is to assess the effect of erythromycin on the Rate of Success in Placement of a Self-propelled Feeding Tube.

Detailed Description

Not available

Study Timeline

• Study Start: 2004-10
• Primary Completion: 2007-07
• Status Verified: 2009-10
• Study First Submitted: 2009-10-20
• Study First Submitted QC: 2009-10-20
• Study First Posted: 2009-10-21
• Last Update Submitted: 2010-01-21
• Last Update Posted: 2010-01-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Aged 18-80 years
• Having pancreatitis
• Require jejunal enteral nutrition

Read More

Exclusion Criteria

• Known impaired peristalsis (critically ill patients, postoperative patients, history of surgery of the stomach/duodenum)
• Pregnancy
• Hypersensibility to erythromycin
• Cardiac arrhythmias with a prolonged QT-time
• Simultaneous usage of drugs impairing peristalsis

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Placebo	Placebo	-
Erythromycin	Erythromycin	-

Primary Outcome Measures

Name	Time	Method
The success rate of spontaneous positioning the tubes tip into the jejunum, beyond Treitz ligament, after 48 hours.

Secondary Outcome Measures

Name	Time	Method
The success rate of spontaneous positioning the tubes tip into the jejunum, beyond Treitz ligament, after 24 hours.
Adverse events using this self-propelled tube